Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
Status:
Withdrawn
Trial end date:
2016-05-15
Target enrollment:
Participant gender:
Summary
Macular edema is the most common sight threatening complication of uveitis which can lead to
permanent loss of central vision. Triamcinolone acetonide ( the study drug)injection for
treatment of cystoid macular edema(CME) is well established. The purpose of this study is to
compare the safety and efficacy of injecting the study drug inside the eye(intravitreal
injection) and behind the eye(subtenon injection)